Εμφάνιση απλής εγγραφής

dc.creatorSymeonidis, C.en
dc.creatorKaprinis, K.en
dc.creatorManthos, K.en
dc.creatorAndroudi, S.en
dc.creatorAnastassilakis, K.en
dc.creatorDimitrakos, S. A.en
dc.date.accessioned2015-11-23T10:49:09Z
dc.date.available2015-11-23T10:49:09Z
dc.date.issued2011
dc.identifier10.1159/000324701
dc.identifier.issn16632699
dc.identifier.urihttp://hdl.handle.net/11615/33493
dc.description.abstractPurpose: Central serous chorioretinopathy (CSCR) manifests as neurosensory detachment of the macula and can be attributed to focal or multifocal leakage in the retinal pigment epithelium (RPE). Fibrin accumulation in the subretinal space is an unusual and heretofore unreported visually damaging manifestation of severe CSCR. Methods: The patient was followed up with the use of biomicroscopy, fluorescein angiography, and optical coherence tomography (OCT). Results: A 32-year-old woman was referred to our department complaining of metamorphopsia and decreased visual acuity in the right eye. Best-corrected visual acuity (BCVA) was 20/40 in the right eye and 20/20 in the left eye. Biomicroscopy revealed an irregularly shaped foveal elevation and wrinkling in the right eye. OCT showed a steep neurosensory retina elevation with a highly reflective material accumulation in the subretinal space, presumably fibrin. Our diagnosis was CSCR complicated by subretinal fibrin accumulation. Since most of these cases resolve spontaneously, the patient was kept under observation; 1 month later, the fibrin accumulation had expanded subfoveally (BCVA 20/200). The patient was offered 3 intravitreal ranibizumab injections. After the initial injection, BCVA improved to 20/50 and, after the 3 injections, to 20/30. Two months later (BCVA 20/30), fresh leakage was observed at the margin of the original lesion, and an additional intravitreal ranibizumab injection was performed. After another 2 months, BCVA stabilized at 20/25 and remained stable throughout the 12 months after the initial injection. Conclusions: Prompt recognition of CSCR complicated by subretinal fibrin and immediate intervention may result in recovery from this potentially devastating complication. Ranibizumab may be an alternative treatment option in the management of refractory CSCR complicated by subretinal fibrin accumulation. Copyright © 2011 S. Karger AG, Basel.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-79957592130&partnerID=40&md5=dfb92172b7369524f7300e3d4ffb5212
dc.subjectCentral serous chorioretinopathyen
dc.subjectFibrinen
dc.subjectOptical coherence tomographyen
dc.subjectRanibizumaben
dc.subjectadulten
dc.subjectarticleen
dc.subjectbiomicroscopyen
dc.subjectcase reporten
dc.subjectcentral serous retinopathyen
dc.subjectfemaleen
dc.subjectfibrin depositionen
dc.subjectfollow upen
dc.subjecthumanen
dc.subjectpriority journalen
dc.subjectretina detachmenten
dc.subjectretina fluorescein angiographyen
dc.subjectretina foveaen
dc.subjectvisual acuityen
dc.titleCentral serous chorioretinopathy with subretinal deposition of fibrin-like material and its prompt response to ranibizumab injectionsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής